- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01561144
UMBRELLA - Incidence of Arrhythmias in Spanish Population With a Medtronic Implantable Cardiac Defibrillator Implant (UMBRELLA)
January 29, 2018 updated by: Medtronic Bakken Research Center
UMBRELLA - Incidence of Arrhythmias in Spanish Population With a Medtronic ICD Implant
The purpose of the study is to analyze the different patient profiles implanted with an Implantable Cardiac Defibrillator (ICD) in Spain (guidelines adoption) and the patient prognosis as a function of clinical profile, implant indication, arrhythmias incidence, treatments or device programming.
Study Overview
Status
Terminated
Conditions
Detailed Description
Umbrella is a prospective and retrospective cohort study.
Study Type
Observational
Enrollment (Actual)
4648
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Alicante, Spain
- H. General de Alicante
-
Alicante, Spain
- H. Universitario San Juan de Alicante
-
Almería, Spain
- Complejo Hospitalario Torrecárdenas de Almería
-
Badajoz, Spain
- H. Infanta Cristina
-
Barcelona, Spain
- H. de la Santa Creu i Sant Pau
-
Barcelona, Spain
- H. Clínic i Provincial de Barcelona
-
Bilbao, Spain
- H. de Basurto
-
Burgos, Spain
- H. Universitario de Burgos
-
Ciudad Real, Spain
- H. Gral de Ciudad Real
-
Cáceres, Spain
- H. San Pedro de Alcántara
-
Cáceres, Spain
- Complejo Hospitalario de Caceres
-
Córdoba, Spain
- H. Reina Sofia
-
Granada, Spain
- H.Universitario Virgen de las Nieves
-
Guadalajara, Spain
- H.Universitario de Guadalajara
-
La Coruña, Spain
- Complejo Hospitalario Universitario A Coruna
-
Las Palmas de Gran Canaria, Spain
- H. Universitario Insular de las Palmas
-
León, Spain
- H. de León
-
Madrid, Spain
- H. Clínico San Carlos
-
Madrid, Spain
- H. Infanta Leonor
-
Madrid, Spain
- H. Universitario 12 de octubre
-
Madrid, Spain
- H. Universitario Gregorio Marañón
-
Madrid, Spain
- H. Universitario La Paz
-
Madrid, Spain
- H. Universitario Ramón y Cajal
-
Murcia, Spain
- H. General Universitario Reina Sofía
-
Murcia, Spain
- H. Universitario Virgen de la Arrixaca
-
Málaga, Spain
- H. Clínico Virgen de la Victoria
-
Palma de Mallorca, Spain
- H. Son Llàtzer
-
Pamplona, Spain
- H. de Navarra
-
Santa Cruz de Tenerife, Spain
- H.Universitario Nuestra Señora de Candelaria
-
Santander, Spain
- H. Universitario Marqués de Valdecilla
-
Sevilla, Spain
- H. Universitario Nuestra Señora de Valme
-
Sevilla, Spain
- H. Universitario Virgen Macarena
-
Tarragona, Spain
- H. Universitario Joan XXIII
-
Toledo, Spain
- Complejo Hospitalario de Toledo
-
Valencia, Spain
- H. General Universitario de Valencia
-
Valencia, Spain
- H. Universitario la Fe
-
Valladolid, Spain
- H. Clínico Universitario de Valladolid
-
Vigo, Spain
- Complejo Hospitalario Universitario de Vigo
-
-
Alicante
-
Elche, Alicante, Spain
- H. General Universitario de Elche
-
-
Araba
-
Vitoria, Araba, Spain
- H. de Txagorritxu
-
-
Asturias
-
Oviedo, Asturias, Spain
- H. Universitario Central de Asturias
-
-
Barcelona
-
Badalona, Barcelona, Spain
- H. Universitari Germans Trias i Pujol
-
L'Hospitalet de Llobregat, Barcelona, Spain
- H. Universitari de Bellvitge
-
-
Coruña
-
Santiago de Compostela, Coruña, Spain
- Complejo Hospitalario de Santiago
-
-
Guipúzcoa
-
Donostia, Guipúzcoa, Spain
- Complejo Hospitalario Donostia
-
-
Madrid
-
Majadahonda, Madrid, Spain
- H. Puerta de Hierro - Majadahonda
-
-
Murcia
-
Lorca, Murcia, Spain
- H. Rafael Méndez
-
-
Santa Cruz De Tenerife
-
San Cristobal de la Laguna, Santa Cruz De Tenerife, Spain
- H. Universitario de Canarias
-
-
Valencia
-
Alzira, Valencia, Spain
- H. Universitario De La Ribera
-
-
Vizcaya
-
Barakaldo, Vizcaya, Spain
- H. de Cruces
-
Galdakao, Vizcaya, Spain
- H. Galdakao - Usansolo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years and older (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients inplanted with an Implantable Cardiac Defibrillator (ICD) according to guidelines.
Description
Inclusion Criteria:
- Patients with a Medtronic Implantable Cardiac Defibrillator (ICD) according to guidelines.
- Patients with CareLink home Telemonitoring System.
Exclusion Criteria:
- Unwillingness or inability to sign study written informed consent and/or CareLink consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To assess the number of ventricular and atrial arrhythmias, and atrial fibrillation burden detected by ICD.
Time Frame: End of the study, an expected duration of 5 years.
|
End of the study, an expected duration of 5 years.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Briongos-Figuero S, Garcia-Alberola A, Rubio J, Segura JM, Rodriguez A, Peinado R, Alzueta J, Martinez-Ferrer JB, Vinolas X, Fernandez de la Concha J, Anguera I, Martin M, Cerda L, Perez L; UMBRELLA Investigators *. Long-Term Outcomes Among a Nationwide Cohort of Patients Using an Implantable Cardioverter-Defibrillator: UMBRELLA Study Final Results. J Am Heart Assoc. 2021 Jan 5;10(1):e018108. doi: 10.1161/JAHA.120.018108. Epub 2020 Dec 25.
- Loughlin G, Datino T, Arenal A, Ruiz-Granell R, Sanchez-Gomez JM, Perez L, Martinez-Ferrer J, Alzueta J, Perez-Lorente F, Vinolas X, Fidalgo Andres ML, Fernandez de la Concha J. Predictors of adoption and impact of evidence-based programming on the incidence of implantable cardioverter-defibrillator therapies. Rev Esp Cardiol (Engl Ed). 2021 Apr;74(4):296-302. doi: 10.1016/j.rec.2020.06.017. Epub 2020 Aug 6. English, Spanish.
- Lillo-Castellano JM, Marina-Breysse M, Gomez-Gallanti A, Martinez-Ferrer JB, Alzueta J, Perez-Alvarez L, Alberola A, Fernandez-Lozano I, Rodriguez A, Porro R, Anguera I, Fontenla A, Gonzalez-Ferrer JJ, Canadas-Godoy V, Perez-Castellano N, Garofalo D, Salvador-Montanes O, Calvo CJ, Quintanilla JG, Peinado R, Mora-Jimenez I, Perez-Villacastin J, Rojo-Alvarez JL, Filgueiras-Rama D. Safety threshold of R-wave amplitudes in patients with implantable cardioverter defibrillator. Heart. 2016 Oct 15;102(20):1662-70. doi: 10.1136/heartjnl-2016-309295. Epub 2016 Jun 13.
- Anguera I, Dallaglio P, Martinez-Ferrer J, Rodriguez A, Alzueta J, Perez-Villacastin J, Porres JM, Vinolas X, Fontenla A, Fernandez-Lozano I, Garcia-Alberola A, Sabate X. Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study. J Cardiovasc Electrophysiol. 2015 Jul;26(7):774-82. doi: 10.1111/jce.12699. Epub 2015 May 28.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2011
Primary Completion (Actual)
November 1, 2017
Study Completion (Actual)
November 1, 2017
Study Registration Dates
First Submitted
March 16, 2012
First Submitted That Met QC Criteria
March 21, 2012
First Posted (Estimate)
March 22, 2012
Study Record Updates
Last Update Posted (Actual)
January 30, 2018
Last Update Submitted That Met QC Criteria
January 29, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UMBRELLA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiomyopathies
-
St. Jude Children's Research HospitalRecruitingChildhood Cancer | Cardiomyopathy, PrimaryUnited States
-
Nantes University HospitalUniversity Hospital, Angers; University Hospital, Brest; University Hospital,...Not yet recruiting
-
Yale UniversityPfizerRecruitingCardiomyopathies, PrimaryUnited States
-
Medical University of WarsawRecruitingHeart Failure | Myocarditis | Immunosuppression | Cardiomyopathies, Secondary | Endomyocardial BiopsyPoland
-
Centre Hospitalier Universitaire de NiceTerminatedDiabetic CardiomyopathiesFrance
-
Groupe Hospitalier Paris Saint JosephCompleted
-
University Hospital BirminghamBritish Heart FoundationUnknownDiabetic CardiomyopathyUnited Kingdom
-
Applied Therapeutics, Inc.Active, not recruitingDiabetic CardiomyopathiesUnited States, France, Spain, Australia, Canada, United Kingdom, Germany, Czechia, Hong Kong, Poland
-
University Hospital, Strasbourg, FranceUnknown
-
Xinhua Hospital, Shanghai Jiao Tong University...UnknownDiabetic Cardiomyopathies